The Influence of Circulating Tumor DNA Analysis on Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Grinberg, R. [1 ]
Roisman, L. [1 ]
Geva, S. [2 ]
Lefterova, M. [3 ]
Quinn, K. [3 ]
Gutman, L. Soussan [4 ]
Dvir, A. [4 ]
Yair, R. [4 ]
Twito, T. [4 ]
Lanman, R. [3 ]
Peled, N. [1 ]
机构：
[1] Soroka Univ, Canc Inst, Med Ctr, Beer Sheva, Israel
[2] Rabin Med Ctr, Davidoff Canc Ctr, Thorac Canc Serv, Petah Tiqwa, Israel
[3] Guardant Hlth, Redwood City, CA USA
[4] Oncotest Teva Pharmaceut Ltd, Petah Tiqwa, Israel
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
TMB; Immunotherapy; ctDNA;
D O I：
10.1016/j.jtho.2018.08.1718
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.04-11
引用
收藏
页码：S925 / S926
页数：2
相关论文
共 50 条
  • [1] The influence of circulating tumor DNA analysis on response to immunotherapy in non-small cell lung cancer (NSCLC)
    Grinberg, R.
    Roisman, L. C.
    Geva, S.
    Soussan-Gutman, L.
    Dvir, A.
    Yair, R.
    Twito, T.
    Larman, R.
    Peled, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S35 - S36
  • [2] Assessing response to immunotherapy in patients with non-small cell lung cancer using circulating tumor DNA
    Goldberg, S. B.
    Narayan, A.
    Kole, A. J.
    Decker, R. H.
    Teysir, J.
    Carriero, N. J.
    Lee, A.
    Nemati, R.
    Nath, S. K.
    Mane, S. M.
    Deng, Y.
    Sukumar, N.
    Zelterman, D.
    Boffa, D. J.
    Politi, K.
    Gettinger, S. N.
    Wilson, L. D.
    Herbst, R. S.
    Patel, A. A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [4] Methylation based circulating tumor DNA serial monitoring correlates with immunotherapy response in non-small cell lung cancer
    Hsiao, Angela
    Woodward, Brian
    Ye, Patrick
    Varga, Matthew
    Lu, Kevin
    Altaie, Ghaith
    Searle, Naomi
    Veins, Robb
    Langpap, Sydne
    Li, Zeqian
    Palmer, Gary
    Husain, Hatim
    CLINICAL CANCER RESEARCH, 2024, 30 (21)
  • [5] Role of circulating-tumor DNA analysis in non-small cell lung cancer
    Jiang, Tao
    Ren, Shengxiang
    Zhou, Caicun
    LUNG CANCER, 2015, 90 (02) : 128 - 134
  • [6] Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review
    Indini, Alice
    Rijavec, Erika
    Grossi, Francesco
    CANCERS, 2021, 13 (08)
  • [7] Detection and application of circulating tumor cell and circulating tumor DNA in the non-small cell lung cancer
    Zhang, Yuting
    Zheng, Hongmei
    Zhan, Yuting
    Long, Mengping
    Liu, Sile
    Lu, Junmi
    Zang, Hongjing
    Fan, Songqing
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (12): : 2377 - 2386
  • [8] Prognostic Role of Circulating Tumor DNA (ctDNA) and Immune Cell Biomarkers in Non-Small Cell Lung Cancer (NSCLC)
    Chae, Y. K.
    Agte, S.
    Davis, A.
    Pan, A.
    Simon, N.
    Mohindra, N.
    Villaflor, V.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2242 - S2242
  • [9] Circulating free tumor DNA in non-small cell lung cancer (NSCLC): clinical application and future perspectives
    Herbreteau, Guillaume
    Vallee, Audrey
    Charpentier, Sandrine
    Normanno, Nicola
    Hofman, Paul
    Denis, Marc G.
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S113 - S126
  • [10] Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
    Yang, Jialiang
    Hui, Yan
    Zhang, Yanxiang
    Zhang, Minghui
    Ji, Binbin
    Tian, Geng
    Guo, Yangqiang
    Tang, Min
    Li, Lianxing
    Guo, Bella
    Ma, Tonghui
    FRONTIERS IN ONCOLOGY, 2021, 11
12345